ASHUMGulf news and Dubai stocks, live

Financial statements for the period from January 2019 to June 2021 CHAE

Lunate S&P UAE UCITS ETF - Share A - ACCUMLATING 27 pages

Document27 pages, text from the fileOpen DFM’s file

Page 1

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

ICAV Registration Number: C188915

Page 2

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

ContentsPage

Directors and Other Information 1

Investment Manager’s Report 2

Statement of Financial Position 4

Statement of Comprehensive Income 5

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 6

Statement of Cash Flows 7

Notes to the Unaudited Financial Statements 8

Schedule of Investments 22

Statement of Portfolio Changes 23

Appendix I: Securities Financing Transactions Regulation (“SFTR”) Disclosures

25

Page 3

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

1Directors and Other InformationDirectors of the ICAVHamad Al Shamsi1,3Feargal Dempsey 1Seif Fikry 2Adrian Mulryan 1Majed Odeh 1Jason Loveless 2,4

Registered Office of the ICAV3-4 Upper Pembroke StreetDublin 2Ireland

Manager

FundRock Management Company S.A.

33, rue de GasperichL-5826 HesperangeGrand-Duchy of Luxembourg

Investment Manager and Global Distributor Chimera Capital Limited

3502, 35th Floor, Al Maqam Tower ADGM Square

Al Maryah IslandAbu DhabiUnited Arab Emirates

Depositary

The Bank of New York Mellon SA/NV, Dublin Branch Riverside II

Sir John Rogerson’s QuayGrand Canal DockDublin 2Ireland

Administrator, Registrar and Transfer AgentBNY Mellon Fund Services (Ireland)Designated Activity CompanyOne Dockland CentralGuild Street

International Financial Services Centre Dublin 1

Ireland

Secretary

FundRock Management Company S.A.

3-4 Upper Pembroke StDublin 2Ireland

Independent AuditorsDeloitte Ireland LLP29 Earlsfort TerraceDublin 2Ireland

Irish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2Ireland

International Legal AdvisersHerbert Smith Freehills LLP

Dubai International Financial Centre Gate Village 7, Level 4

PO Box 506631DubaiUAE

1 Independent and Non-executive Director.

2 Non-executive Director.3 Resigned on 28 June 2021.4 Appointed on 28 June 2021.

Page 4

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

2Investment Manager’s Report

Fund Performance

The Chimera S&P UAE UCITS ETF (the “Fund”) was laun ched on 23 February 2021 at a price of AED 3.67 per share. Class D

Distributing Shares was listed on the Abu Dhabi Sec urities Exchange (ADX) on 23 February 2021, and Cla ss A Accumulating

Shares was listed on the Dubai Financial Market (“D FM”) on 3 March 2021.

This report covers the period from launch date on 23 February 2021 to 30 June 2021.

For the period from launch date to 30 June 2021, th e total return for the Fund was +14.71% versus the S&P UAE BMI Liquid 20/35 Capped Index’s (the “Index”) rise of 15.27%. On 23 June 2021, Chimera S&P UAE UCITS ETF’s ADX-li sted class distributed a dividend of AED 0.096 per share, impl ying a dividend yield of 2.27% based on the pre-div idend price of AED 4.23 on 22 June 2021. As per the prospectus, the Fund intends to pay a dividend twice a year, in June and December, when available.

Tracking Difference

From launch date to 30 June 2021, the total return for the Fund was +14.71% based on the performance o f Class A Accumulating Share versus the Index’s rise of 15.27%, with a tra cking difference of 0.554%. The tracking differenc e is broken down in the table below:

SINCE INCEPTIONETF Return 14.71%Index Return 15.27%Tracking Difference (bps) -55.4Total Expense Ratio (bps) 26.9Tracking Error Net (bps) -28.5

Of the 0.554% tracking difference, 0.269% is manage ment fees, indicating that the net tracking differe nce for the period under review was 0.285%. In March and April 2021, the Fun d’s performance was impacted by a cash drag due to the time it takes for companies to pay the dividend after the ex-dividend date, resulting in a cash receivable for several days or weeks.

The ETF’s annualised tracking difference would come to 1.59%.

As stated in the Investment Policy of the Chimera S &P UAE UCITS ETF Prospectus, a maximum level of tra cking difference, which is up to 2% (net of fees) per annum will be maintained.

Page 5

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

3Investment Manager’s Report (continued)

Assets Under Management

The assets under management of the Chimera S&P UAE UCITS ETF Fund as of 30 June 2021 were AED 61.8 mil lion; Class D Distributing Shares, listed on the Abu Dhabi Securi ties Exchange was AED 59.7 million and the Class A Accumulating Shares, listed on the Dubai Financial Market was AED 2.1 million.

The Fund was rebalanced twice since it was launched and during that time, DXB Entertainment was droppe d from the Index, bringing the total number of constituents from 23 s tocks to 22. DXB Entertainment was removed because the company’s largest shareholder made a tender offer to take the company private in May 2021.

Market Commentary

The United Arab Emirates (“UAE”) markets have had s trong performances this year to date supported by a n improving economy on the back of one of the most successful vaccinati on programs in the world where the UAE now ranks as one of the countries with the highest percentage of residents vaccinated. This has allowed the country to open its economy, with relevant restrictions in place to ensure health safety. While tourism is no t expected to return to pre-pandemic levels for som e time, retail and food and beverage activity has been vibrant. The positive se ntiment brought on by the re-opening has translated into a strong performance for the UAE stock markets. While both stock markets in the UAE have risen so far this year, the ADX ha s outperformed the DFM, rising 35.5% versus the DFM’s 12.8%. Trading on the ADX has averaged AED 1.2 billion (US$316 million) per day, far exceeding the DFM’s AED 227 million (US$62 million) . During 2021, trading activity on the ADX was also supported by the listing of three companies, helping the Index surpass AED 1 trillion (US$272 billion) in market capitalisation.

The strong performance of the stock markets up to t he end of June is a reflection of investors’ expect ations of UAE companies recovering from the pandemic-induced slowdown. Fir st quarter results were encouraging; the banking se ctor’s lower provisioning costs coupled with an uptick in real estate sales has provided support for the two biggest sectors in the market. The UAE real estate sector is showing signs of recovery this so far yea r. While pent-up demand from last year supported th e demand recovery in the first quarter of 2021, sustained momentum into the second quarter of 2021 indicates improving confiden ce in the sector, with increasing end-user demand. These developments have helped push up stock prices of Aldar Properties on ADX, and Emaar Properties and Emaar Development on DFM. In the ban king sector, most of the banks maintained their div idend pay-outs for 2020, which gave investors confidence in banks weat hering of the economic slowdown. Following the firs t quarter results, banks have guided for loan growth to start materialising during the second half of the year, giving investor s added comfort with a rebound in the economic growth trajectory. Investo r optimism was reflected in the rise of First Abu D habi Bank to all-time highs in May, and Emirates NBD also delivered significant returns of 28.6% in the first half of 2021, outperforming the DFM market.

In the telecom sector, Etisalat gained 30.2% on the back of the company reporting profit growth in 202 0, and dividends were maintained, following an additional one-off dividend in 2020, which translated into a dividend yield of 5.4%. Other stocks that had double-digit returns were ADNOC Distribution, Abu Dhabi Islamic Bank and Dana Gas.

The outlook for the UAE stock markets is positive p rovided that the rebound in the current economic ac tivity is maintained.

Market data suggests that the corporate results are starting to improve and should continue to do so, provided there is no resurgence in the Covid-19 pandemic. Dubai is set t o host Expo 2020 giving some support to the positiv e sentiment in the DFM, and for the ADX, a number of high profile companies are scheduled for intial public offerings (“IPOs”) in the second half of the year, which should help maintain interest in the market while also increasing its sector diversity.

Chimera Capital LimitedDate: July 2021

Page 6

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

4Statement of Financial Position

Chimera S&P UAEUCITS ETF*

As at30 June2021Notes AED

Assets

Cash and cash equivalents 2(m),599,681

Financial assets at fair value through profit or loss: 2(b), (o)Transferable securities 61,819,864Total assets 61,919,545

LiabilitiesAccrued Management fees (139,252)Total liabilities (139,252)

Net assets attributable to holders of redeemable participating shares 61,780,293

Number of redeemable participating Shares

Class A Accumulating Shares3500,000

Class D Distributing Shares314,500,000

Net asset value per share attributable to holders of redeemable participating Shares

Class A Accumulating Shares 13 AED 4.210Class D Distributing Shares 13 AED 4.116

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

The accompanying notes form an integral part of the unaudited financial statements.

Page 7

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

5Statement of Comprehensive Income

Chimera S&P UAEUCITS ETF*

Financial period from23 February2021 to30 June2021Notes AED

IncomeDividend income 2(e) 880,609

Net gains on financial assets at fair value through profit or loss 2(i),44,978,438

Total investment income 5,859,047

Operating expenses

Management fees7(139,252)

Total operating expenses (139,252)

Net income 5,719,795

Finance costs

Distributions to holders of redeemable participating shares15(1,392,000)

Interest expense 2(f) (2)Total Finance costs (1,392,002)

Profit for the period before tax 4,327,793

Increase in net assets resulting from operations attributable to holders of redeemable participating shares 4,327,793

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

Gains and losses arose solely from continuing inves tment activities. There were no gains or losses oth er than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of the unaudited financial statements.

Page 8

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

6

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares

Chimera S&P UAEUCITS ETF*

Financial period from23 February2021 to30 June2021AED

Net assets attributable to holders of redeemable participating shares at beginning of the period –

Increase in net assets resulting from operations attributable to holders of redeemable participating shares 4,327,793

Amounts received on issue of redeemable participating shares 57,452,500

Increase in net assets resulting from share transactions 57,452,500

Net assets attributable to holders of redeemable participating shares at end of the period 61,780,293

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

The accompanying notes form an integral part of the unaudited financial statements.

Page 9

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

7

Statement of Cash Flows

Chimera S&P UAEUCITS ETF*

Financial period from23 February2021 to30 June2021Notes AED

Cash flows from operating activitiesProceeds from sale of investments 1,393,430Purchase of investments** (782,356)Dividend income received 880,609Net cash inflow from operating activities 1,491,683

Cash flows from financing activitiesDistributions paid to holders of redeemable participating shares 15 (1,392,000)Interest expense paid (2)

Amounts received on issue of redeemable participating shares** – Net cash outflow from financing activities (1,392,002)

Net increase in cash and cash equivalents 99,681

Cash and cash equivalents at beginning of period –Cash and cash equivalents at end of the period 2(m), 5 99,681

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

** The Sub-Fund engaged in in-kind issues of redeem able participating shares during the financial peri od amounting to AED 57,452,500 (refer to Note 2 (g) and Note 3 to the f inancial statements for further details on these ty pes of transactions). All the subscriptions into the Sub-Fund to date, were achie ved via in-kind contribution of assets of the same amount representing consideration for purchase of investments

The accompanying notes form an integral part of the unaudited financial statements.

Page 10

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements8

1. Organisation

Chimera UCITS ICAV (the ‘’ICAV’’) is an Irish colle ctive asset-management vehicle registered in Irelan d pursuant to the Irish Collective Asset-Management Vehicles Act 2015 (the “ICAV Act”) on 21 January 2019 with registration nu mber C188915 and was authorised by the Central Bank of Ireland (the “CBI”) on 18 November 2020 as an Undertaking for Co llective Investment in Transferable Securities (“UCITS”) under the provisi ons of the European Communities (Undertakings for C ollective Investment in Transferable Securities) Regulations 2011, (as amen ded) (the “UCITS Regulations”) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securiti es) (Amendment) Regulations 2019 (the "Central Bank UCITS Regulations").

The ICAV is structured as an umbrella fund with seg regated liability between Funds (individually a “Su b-Fund” and collectively “Sub-Funds”). The Instrument of Incorporation provi des that the ICAV may offer separate classes of sha res, each representing interests in a Sub-Fund comprising a distinct portf olio of investments. In addition, each Sub-Fund may be further divided into a number of different classes within the Sub-Fund. Wi th the prior approval of the CBI, the ICAV from tim e to time may create additional Sub-Funds. The creation of further share classes shall be notified to and prepared and subm itted to the CBI in accordance with the CBI requirements.

As at 30 June 2021, the ICAV consisted of one Sub-F und, Chimera S&P UAE UCITS ETF which was launched o n 23 February 2021.

The Sub-Fund seeks to provide investors with a tota l return, taking into account capital and income re turns, which reflects the return of an equity index called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”).

The Index is a modified weighted total return index measuring the performance of the top United Arab E mirates ("UAE") domiciled companies ranked in the S&P UAE BMI Index . The S&P UAE BMI Index is a leading benchmark for tracking performance of the UAE equity markets. The Index is comprised of the constituents of the S&P UAE BMI I ndex that meet the following eligibility requirements: (i) companies m ust have no more than ten non-trading days over the previous quarter; and (ii) have a three-month average daily value traded volum e of at least US$ 500,000 for at least one of the t wo quarterly periods preceding the rebalancing reference date.

In order to achieve its investment objective, the i nvestment policy of the Sub-Fund is to invest 100% of its net assets in a portfolio of equity securities that consists of the equity se curities of the Index. The Investment Manager may d eviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.

The Sub-Fund attempts to replicate, before fees and expenses, the performance of the Index. The Invest ment Manager will seek to do this by replicating so far as possible the inves tments in the Index by holding all of the securitie s comprising the Index in approximately the same proportion as its weighting in the Index.

The base currency of the Sub-Fund is the United Ara b Emirates Dirham ("AED"). The Net Asset Value per Share will be published and settlement and dealing will be effected in the designated currency of each Class.

The shares of the active Sub-Fund are listed and ad mitted for trading on the following stock exchanges : Class A Accumulating Shares are listed on the Dubai Financial Market while Class D Distributing Shares are listed on Abu Dhabi Securities Exchange.

2. Significant Accounting Policies

(a) Basis of preparation

These condensed interim report and unaudited financial statements have been prepared in accordan ce with IAS 34, "Interim Financial Reporting", the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations.

The condensed interim report and unaudited statements have been prepared on a going concern ba sis which assumes that the ICAV will continue in operational existence for the foreseeable future and have been prepared under th e historical cost convention, as modified by the revaluation of financial assets and financial liabilities at fair value through profit or loss.

Page 11

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)9

2. Significant Accounting Policies (continued)

(a) Basis of preparation (continued)

The preparation of the condensed interim report and unaudited financial statements in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the reporting date and the reported amounts of revenues and expenses during the reporting perio d. Although these estimates are based on management ’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.

The Directors make estimates and assumptions concer ning the future of the ICAV. The resulting accounti ng estimates will, by definition, seldom equal the related actual results . There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.

International Financial Reporting Standards

At the date of approval of these unaudited financia l statements, all standards, amendments and interpr etations to existing standards effective for financial periods beginning on or aft er 1 January 2019 and 1 January 2020 have been adop ted by the ICAV. In addition, the following standards, amendments and i nterpretations to existing standards effective for annual periods beginning on or after 1 January 2021 were adopted by the ICAV:

New accounting standards, amendments and interpreta tions in issue and effective for the financial peri ods beginning on or after 1

January 2021

Interest Rate Benchmark Reform - Amendment to IFRS 7, IFRS 9 and IAS 39 (Phase 2)

The amendments address issues that might affect fin ancial reporting during the reform of an interest r ate benchmark, including the effects of changes to contractual cash flows or hed ging relationships arising from the replacement of an interest rate benchmark with an alternative benchmark rate (replacement issues). The amended requirements in IFRS 7, IFRS 9 and IAS 39 relates to:

• changes in the basis for determining contractual cash flows of financial assets and financial liabilities;

• hedge accounting, and;

• disclosures.

The Phase 2 amendments apply only to changes requir ed by the interest rate benchmark reform to financi al instruments and hedging relationships. The amendments apply retrosp ectively with earlier application permitted. Hedgin g relationships previously discontinued solely because of changes resulting fr om the reform will be reinstated if certain conditi ons are met. The amendment is effective for annual reporting periods beginning on or after 1 January 2021.

The adoption of Interest Rate Benchmark Reform - Am endment to IFRS 7, IFRS 9 and IAS 39 (Phase 2) did not have a significant impact on the ICAV’s financial statements.

There are no other standards, amendments to standar ds or interpretations that are effective for annual periods beginning on or after 1 January 2021 that have a material effect on the ICAV’s financial statements.

Standards, interpretations and amendments to existing standards in issue but not yet effective

Onerous Contracts - Cost of Fulfilling a Contract (Amendments to IAS 37)

IAS 37 Provisions Contingent Liabilities and Contin gent Assets did not specify which costs to include in estimating the cost of fulfilling a contract for the purpose of assessing whether that contract is onerous. Research conducte d by the IFRS Interpretations Committee indicated that differing views on which c osts to include could lead to material differences in the financial statements of entities that enter into some types of contracts.

In this project, the IASB developed amendments to I AS 37 to clarify that for the purpose of assessing whether a contract is onerous, the cost of fulfilling the contract includ es both the incremental costs of fulfilling that co ntract and an allocation of other costs that relate directly to fulfilling contracts.

Page 12

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued) 10

2. Significant Accounting Policies (continued)

(a) Basis of preparation (continued)

International Financial Reporting Standards (continued)

The IASB issued the amendments in May 2020. The ame ndments are effective for contracts for which an en tity has not yet fulfilled all its obligations on or after 1 January 2022 with earlier application permitted.

The ICAV is currently evaluating the impact, if any, that this amendment will have on its financial statements.

Annual Improvements to IFRS Standards 2018–2020

The four proposed amendments included in the annual improvements consultation document are:

IFRS 1 First-time Adoption of International Financial Reporting Standards

Simplify the application of IFRS 1 by a subsidiary that becomes a first-time adopter of IFRS Standards after its parent company has already adopted them. The proposed amendment relates to the measurement of cumulative translation differences.

IFRS 9 Financial Instruments

Clarify the fees a company includes in assessing th e terms of a new or modified financial liability to determine whether to derecognise a financial liability. The amendments a re effective for annual reporting periods beginning on or after 1 January 2022 with earlier application permitted.

The ICAV is currently evaluating the impact, if any, that these amendments will have on its financial statements.

Classification of Liabilities as Current or Non-current (Amendments to IAS 1)

The amendments clarify a criterion in IAS 1 for classifying a liability as non-current: the requirement for an entity to have the right to defer settlement of the liability for at least 12 months after the reporting period.

The amendments:

• specify that an entity’s right to defer settlement must exist at the end of the reporting period;

• clarify that classification is unaffected by manage ment’s intentions or expectations about whether the entity will exercise its right to defer settlement;

• clarify how lending conditions affect classification; and

• clarify requirements for classifying liabilities an entity will or may settle by issuing its own equity instruments.

In its Primary Financial Statements project, the IA SB is developing proposals to improve the way infor mation is communicated in financial statements. The IASB proposes to issue requirements in a new IFRS Standard that would replace IAS 1.

The amendments apply retrospectively for annual rep orting periods beginning on or after 1 January 2023 with earlier application permitted. The ICAV is currently evaluating the impact, if any, that these amendments will have on its financial statements.

There are no other standards, interpretations and a mendments to existing standards in issue but not ye t effective that would be expected to have a significant impact on the ICAV.

(b) Financial assets and financial liabilities at fair value through profit or loss

(i) Classification

The ICAV classifies its investment portfolio based on its business model for managing those financial assets and the contractual cash flow characteristics of the financial assets. The portfolio of financial assets is managed and pe rformance is evaluated on a fair value basis. The ICAV is primarily focused on fair value information and uses that information to asse ss the assets’ performance and to make decisions. The ICAV has not taken the o ption to irrevocably designate any equity securitie s as fair value through other comprehensive income. As such, the ICAV class ifies its entire investment portfolio as financial assets or financial liabilities at fair value through profit or loss.

Page 13

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)11

2. Significant Accounting Policies (continued)

(b) Financial assets and financial liabilities at fair value through profit or loss (continued)

(i) Classification (continued)

Financial assets that are not classified at fair va lue through profit or loss include cash and cash eq uivalents and receivables.

Financial liabilities that are not at fair value th rough profit or loss include bank overdraft (if any ) and payables. These other financial assets and financial liabilities are held at amortised cost.

(ii) Recognition, derecognition and measurement

Purchases and sales of investments are recognised o n trade date basis, the date on which the ICAV comm its to purchase or sell the asset. Financial assets and financial liabilities a t fair value through profit or loss are initially r ecognised at fair value. Transaction costs are expensed as incurred in the Statement of Comprehensive Income.

Investments are derecognised when the rights to receive cash flows from the investments have expired o r the ICAV has transferred substantially all risks and rewards of ownership and a realised gain or loss is recognised. Realised g ains and losses are presented in the Statement of Comprehensive Income under “net ga in/(loss) on financial assets at fair value through profit or loss”.

Subsequent to initial recognition, all financial as sets and financial liabilities at fair value throug h profit or loss are measured at fair value. Gains and losses arising from changes in the fair value of the financial assets or financial li abilities at fair value through profit or loss are presented in the Statement of Co mprehensive Income within “net gain/(loss) on finan cial assets at fair value through profit or loss”.

(iii) Fair value estimation

Equity instruments listed, traded or dealt on a reg ulated market for which market quotations are readi ly available shall be valued at the last traded price at the valuation point in the relevant regulated market on the relevant dealing day, provided that the value of the investment listed, traded or dealt in on a regu lated market but acquired or traded at a premium or at a discount outside or off the relevant stock exchange may be valued, taking i nto account the level of premium or discount as at the date of valuation of the investment and The Bank of New York Mellon SA/NV, D ublin Branch (the “Depositary”) must ensure that th e adoption of such procedure is justifiable in the context of establishing the probable realisation value of the security.

If prices for an investment listed, traded or dealt in on the relevant regulated market are not availa ble at the relevant time or are unrepresentative, or in the event that any investme nts are not listed or traded on any regulated marke t, such investment shall be valued at such value as shall be certified with car e and good faith as the probable realisation value of the investment by a competent professional person appointed by the Dire ctors and approved for such purpose by the Deposita ry which may be the Investment Manager.

In the event of it being impossible or incorrect to carry out a valuation of a specific investment in accordance with the valuation rules set out above or if such valuation is not rep resentative of an asset's fair market value, a comp etent person appointed by the ICAV and approved for the purpose by the Depositary is entitled to use such other generally recognised valuation method in order to reach a proper valuation of that specific instru ment, provided that such method of valuation has be en approved by the Depositary and the method used shall be clearly documented.

No instruments have been valued in this manner as at 30 June 2021.Impairment

The ICAV recognises loss allowances of expected cre dit loss (“ECL”) on financial assets measured at am ortised cost. When determining whether the credit risk of a financial asset has increased significantly since initial rec ognition and when estimating ECLs, the ICAV considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative informat ion and analysis, based on the ICAV's historical ex perience and informed credit assessment and including forward–looking informatio n.

Page 14

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)12

2. Significant Accounting Policies (continued)

(b) Financial assets and financial liabilities at fair value through profit or loss (continued)

(iii) Fair value estimation (continued)

ECLs are a probability–weighted estimate of credit losses. Credit losses are measured as the present v alue of all cash shortfalls (i.e. the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the ICAV expects to receive). ECLs are discounted at the eff ective interest rate of the financial asset. The am ount of expected credit losses is immaterial for financial assets.

(c) Foreign currency translation

(i) Functional and presentation currency

The functional and presentation currency of the Sub -Fund is the AED which is the currency of the prima ry economic environment in which it operates. The functional currency of th e Sub-Fund has been evaluated by the Directors base d on the currency that most faithfully represents the economic effects of the u nderlying transactions, events, investors’ base and conditions. The presentation currency of the ICAV is also the AED.

(ii) Transactions and balances

Monetary assets and liabilities denominated in curr encies other than the functional currency are trans lated into the functional currency at the closing rate of exchange at the per iod end date. Foreign currency transactions are tra nslated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the transl ation at period end exchange rates of monetary asse ts and liabilities denominated in foreign currencies are recognised in the Statement of Comprehensive Income.

All other foreign currency exchange differences rel ating to monetary items, including cash are present ed in the Statement of Comprehensive Income.

Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value are translated at the foreign currency exchange rates ruling at the dates that the values were determined.

(d) Transaction costs

Transaction costs are incurred on the acquisition o r disposal of financial assets or financial liabili ties at fair value through profit or loss. They include fees and commissions paid to age nts, advisors, brokers and dealers, interest or tax es payable in respect of purchase and sale transactions. Transaction costs when incurred are expensed immediately and are included within net gain/loss on financial assets and financial liabilities at fair value through profit and loss in the Statement of C omprehensive Income. Please refer to Note 8 for more details.

(e) Dividend income

Dividends are credited to the Statement of Comprehe nsive Income on the dates on which the relevant sec urities are listed as "ex dividend". Income is shown gross of any non-recover able withholding tax, which is disclosed separately in the Statement of Comprehensive Income, and net of any tax credits.

(f) Interest income and interest expense

Bank interest income and expenses are recognised in the Statement of Comprehensive Income on an effective yield basis.

(g) Redeemable participating shares

Redeemable participating shares are redeemable at t he shareholder’s option and are classified as finan cial liabilities in accordance with IAS 32. Any distributions on these shares are recognised in the Statement of Changes in Net Asset s Attributable to Holders of Redeemable Participating Shares.

Page 15

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued) 13

2. Significant Accounting Policies (continued)

(g) Redeemable participating shares (continued)

Subscriptions and Redemptions (Primary Market)

The Primary Market is the market on which shares of the Sub-Funds are issued by the ICAV to Authorised Participants or redeemed by the ICAV from Authorised Participants. Only Authorised Participants are able to subscribe or redeem shares on the Primary Market.

Subscriptions

Subscription of shares may be settled in cash, in-kind or in a combination of both, at the Manager’s d iscretion.

In-kind subscriptions

A Shareholder may subscribe for shares in-kind in a unit of the minimum subscription amount as set out in the relevant Supplement, or a multiple thereof, in return for a basket of component securities (“Component Securiti es”) and a cash component.

The Component Securities shall comprise some or all of the assets which may be invested in by the rele vant Sub-Fund in accordance with the investment objective and policy of that Sub-Fund and the Depositary must be satisf ied that there is unlikely to be any material prejudice to the existing Shareholders through the acceptance of the in-kind subscription.

Cash subscriptions

While subscriptions will normally only be accepted in-kind, the ICAV may on an exceptional basis accept subscription for shares in cash.

Redemptions

The ICAV may pay redemptions either in kind or in cash.

In-kind redemptions

A Shareholder may effect an in-kind redemption of t heir shares through an interdependent redemption pr ocess whereby (1) the ICAV shall agree to redeem a set number of shares i n the ICAV; and (2) the Shareholder shall agree to purchase the underlying Component Securities at an agreed price.

Cash redemptions

While redemptions will normally only be in-kind, th e ICAV may on an exceptional basis accept a request from a Shareholder to redeem Shares in cash.

Subscriptions and Redemptions (Secondary Market)

Shares may be purchased or sold on the Secondary Ma rket by all investors through a relevant stock exch ange on which the shares are admitted to trading or over the counter.

Shares of a Sub-Fund purchased on the Secondary Mar ket cannot usually be sold directly back to the ICA V. Investors must buy and sell shares on a Secondary Market with the assi stance of an intermediary (e.g. a broker) and may i ncur fees for doing so. In addition, investors may pay more than the current N et Asset Value when buying shares and may receive l ess than the current Net Asset Value when buying shares and may receive less than the current Net Asset Value when selling them.

(h) Expenses

Expenses are recognised in the Statement of Compreh ensive Income on an accruals basis. Only management fees are charged to the Statement of Comprehensive Income and the Manag er is responsible for discharging from the manageme nt fee, the other operational fees and expenses of the ICAV including Directors' fees but excluding establishment expens es are also borne by the Investment Manager.

Page 16

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)14

2. Significant Accounting Policies (continued)

(i) Gains/(losses) on financial assets and liabilities at fair value through profit or loss

All realised and unrealised gains and losses on sec urities are recognised as net gain/(loss) on financ ial assets and financial liabilities at fair value through profit or loss in the Statement of Comprehensive Income. The cost of securities sold is accounted for on an average cost basis.

Unrealised gains and losses consist of movement in the fair value of financial instruments between the opening and closing financial period. Realised gains and losses represe nt the difference between an instrument’s initial c arrying amount and disposal amount, or cash payments.

(j) Cash flows

The ICAV has prepared a Statement of Cash Flows usi ng the direct method, whereby major classes of cash receipts and payments related to operating activities are disclosed.

(k) Dividend policy

The Sub-Fund offers Classes of shares that accumula te income or pay regular dividends out of net incom e and realised and unrealised gains net of realised and unrealised los ses attributable to the relevant share Class. The d istribution of dividends is not guaranteed and is subject to the sole discretion of the Directors.

Accumulating Classes

The Directors currently do not intend to declare or pay dividends with respect to the accumulating classes of shares. Therefore, any net income and realised and unrealised gains net of realised and unrealised losses attributable to the shares of the accumulating classes of shares will be accumulated and reflected in their respective Net Asset Values per Share.

Distributing Classes

For the distributing classes of shares, the Directo rs may declare and pay dividends to the relevant Sh areholders semi-annually on the distribution date. As the Index seeks to track the price performance of the companies contained wi thin the Index and distributions made by those companies, dividends in respect of the distributing classes of shares will be calculated by reference to the embedded reinvested dividends within the Index during the relevant dividend period less taxes, inc luding withholding taxes.

As such, there is no guarantee that any dividend wi ll be paid in respect of the distributing classes. Dividends will be calculated so that any dividend declared will never be more than the excess performance of the total return performa nce of the Sub-Fund. The total return performance of the Sub-Fund is calcula ted by reference to the price return performance of the Index over the relevant calculation period (i.e. the relevant dividend period).

Such dividends shall be paid out of net income and realised and unrealised gains net of realised and u nrealised losses attributable to the relevant share class of the Sub-Fund.

(l) Withholding tax

Dividend and interest income received by the ICAV m ay be subject to withholding tax imposed in the cou ntry of origin, which is shown separately in the Statement of Comprehensive Income.

(m) Cash and cash equivalents and bank overdrafts

Cash comprises of cash on hand and demand deposits. Cash equivalents, if any, are short term, highly l iquid investments with original maturities of three months or less that ar e readily convertible to known amounts of cash and which are subject to insignificant changes in value. Bank overdrafts are short term financing options which are repayable on demand.

(n) Offsetting

Financial assets and financial liabilities are offs et and the net amount reported in the Statement of Financial Position when there is a legally enforceable right to offset the recognise d amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously. As at 30 June 2021, no financial assets and financial liabilities were offset in the Statement of Financial Position.

Page 17

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)15

2. Significant Accounting Policies (continued)

(n) Offsetting (continued)

Income and expenses are presented on a net basis for gains and losses from financial instruments at fair value through profit or loss and foreign exchange gains and losses.

(o) Fair Value

IFRS 13 ‘Fair Value Measurement' requires disclosur e relating to the fair value hierarchy in which fai r value measurements are categorised as assets and liabilities in the Statement of Financial Position.

The disclosures are based on a three-level fair val ue hierarchy for the inputs used in valuation techn iques to measure fair value.

The fair value of financial assets and financial li abilities traded in an active market (such as tradi ng securities) are based on quoted market prices at the close of trading on the reporting date.

A financial instrument is regarded as quoted in an active market if the quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing s ervice, or regulatory agency, and those prices repr esent actual and regularly occurring market transactions on an arm's length basis. These instruments are included within Level 1 of the hierarchy.

The fair value of financial assets and financial li abilities that are not traded in an active market i s determined by using valuation techniques. The ICAV uses a variety of methods and makes assumptions that are based on market conditio ns existing at the reporting date. These instruments are included within Level 2 of the hierarchy. The fair value hierarchy has the following levels:

• Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

• Inputs other than quoted prices included within Lev el 1 that are observable for the asset or liability , either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).

• Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

Transfers are deemed to occur at the end of the financial period.

There were no transfers between levels during the financial period ended 30 June 2021 for the Sub-Fund.

Assets and liabilities not carried at fair value but for which fair value is disclosed

The ICAV’s assets and liabilities (by class) not me asured at fair value at 30 June 2021 but for which fair value is disclosed within the fair value hierarchy are considered Level 2, except for cash and cash equivalents, which are considered Level 1.

Cash and cash equivalents include cash on hand and demand deposits held with banks and brokers.

The table below provides an analysis of financial i nstruments at 30 June 2021 that are measured at fai r value in accordance with IFRS 13:

Chimera S&P UAE UCITS ETF *

Financial Assets at Fair Value through Profit or Loss

As at 30 June 2021

Level 1 Level 2 Level 3 TotalAED AED AED AED

Transferable securitiesEquities 61,819,864– – 61,819,864Total 61,819,864 – – 61,819,864

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

Page 18

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)16

3. Share Capital

The issued share capital of the ICAV shall be not l ess than the currency equivalent of €2 represented by two subscriber shares of no par value and the maximum issued share capital o f the ICAV shall not be more than 500 billion share s of no par value. The share capital of the ICAV shall at all times equal the Net Asset Value of the ICAV .

The subscriber shares entitle the holders to attend and vote at all meetings of the ICAV but do not en title the holders to participate in the dividends or net assets of any Sub-Fund or o f the ICAV. The holders of the subscriber shares sh all have one vote for each subscriber share held.

Each of the shares entitles the Shareholder to part icipate equally on a pro rata basis in the dividend s and net assets of a Fund attributable to the relevant Class in respect of wh ich they are issued, save in the case of dividends declared prior to becoming a Shareholder.

The Directors reserve the right to predesignate any class of shares from time to time, provided that S hareholders in that class shall first have been notified by the ICAV thirty calenda r days in advance that the shares will be predesign ated and shall have been given the opportunity to have their shares redeemed by the ICAV, except that this requirement shall no t apply where the Directors predesignate shares in issue in order to facilitate the creation of an additional class of shares.

Each of the shares entitles the holder to attend an d vote at meetings of the ICAV and of the relevant Sub-Fund represented by those shares. No class of shares confers on the hol der thereof any preferential or pre-emptive rights or any rights to participate in the profits and dividends of any other class of sha res or any voting rights in relation to matters rel ating solely to any other class of shares.

Any resolution to alter the class rights of the sha res requires the approval of three quarters of the holders of the shares represented or present and voting at a general meeting duly convened in accordance with the Instrument of Incorporation.

During the financial period ended 30 June 2021 the number of redeemable shares issued and redeemed were as follows:

Chimera S&P UAEUCITS ETF*

Financial period from23 February2021 to30 June2021

Class A Accumulating Shares

Balance at beginning of period – Shares issued** 500,000

Balance at end of period 500,000

Class D Distributing SharesBalance at beginning of period –Shares issued** 14,500,000Balance at end of period 14,500,000

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

** Includes in-kind share transactions of 500,000 s hares valued at AED 1,835,000 for Class A Accumulat ing Shares and 14,500,000 shares valued at AED 55,617,500 for Class D Distributing Shares respectively.

Page 19

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)17

4. Net Gains/(Losses) on Financial Assets at Fair Value Through Profit or Loss

Chimera S&P UAEUCITS ETF*

Financial period from23 February2021 to30 June2021AEDNet realised gains on sale of financial assets at FVTPL 106,812

Net change in unrealised appreciation on financial assets at FVTPL 4,871,626

Net gains on financial assets at fair value through profit or loss 4,978,438

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

5. Cash and Cash Equivalents

Cash and cash equivalents held at the financial per iod ended 30 June 2021 are held with, The Bank of N ew York Mellon SA/NV, Dublin Branch (the "Depositary").

The Standard & Poor’s long term credit rating of th e Depositary was AA- at 30 June 2021.

6. Taxation

Under current law and practice, the ICAV qualifies as an investment undertaking as defined in Section 739B of the Taxes Consolidation Act, 1997, as amended. On that basis, it is not chargeable to Irish tax on its income or gains.

However, Irish tax may arise on the happening of a "chargeable event". A chargeable event includes any distribution payments to Shareholders, any encashment, redemption, cancellat ion or transfer of Shares and the holding of Shares at the end of each eight year period beginning with the acquisition of such Shares.

No Irish tax will arise on the Sub-Fund in respect of chargeable events in respect of:

(a) transactions by a Shareholder who is neither Ir ish resident nor ordinarily resident in Ireland for tax purposes at the time of the chargeable event, provided the appropriate valid de clarations, in accordance with the provisions of th e Taxes Consolidation Act, 1997, as amended, are held by the Sub-Fund or the S ub-Fund has been authorised by the Irish Revenue to make gross payments in the absence of appropriate declarations; and

(b) transactions by certain exempted Irish resident Shareholders who have provided the Sub-Fund with t he necessary signed statutory declarations.

Dividends, interest and capital gains, (if any), re ceived on investments made by the Sub-Fund may be s ubject to taxes imposed by the country from which the investment income/gains are received, and such taxes may not be recoverable by the Sub-Fund or its Shareholders.

7. Expenses

The ICAV shall pay to the Manager out of the Sub-Fu nd’s assets an annual Management Fee of 1% of the S ub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of manage ment services and such other services as have been agreed with the Manager, incl uding the provision of company secretarial services , MLRO services and the maintenance of the ICAV’s beneficial ownership regi ster) out of the Management Fee and any reasonable and properly vouched expenses as well as extraordinary expenses outside the ordinary course of business where agreed in adv ance with the ICAV and shall further discharge all fees and expenses related to the Sub-Fund.

Page 20

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)18

7. Expenses (continued)

The following expenses will be discharged by the Ma nager out of the Management Fee: fees payable to th e Depositary, Administrator, Investment Manager, Global Distribut or and Directors and all operational expenses, incl uding but not limited to, expenses and reasonable out of pocket expenses of t he Depositary, Administrator, Investment Manager, G lobal Distributor and Directors, the costs of maintaining the Sub-Funds a nd any registration of the Funds with any governmen tal or regulatory authority; the costs of registering a Fund in other jurisdicti ons or with any stock exchange, filing fees; prepar ation, printing, and posting of the Prospectus and other prospectuses, sales litera ture and reports to shareholders, regulatory fees o f the Central Bank and other governmental agencies; insurance premiums; fees and expenses for legal, audit, other professionals and other services; levies incurred in connection with acquiring or disposing of Investments or in connection with creation and r edemption transactions including any fees and expenses payable as a result of entering into FDI transactions or arising from investment in collective investment schemes (including, without limitation, any fees, charges, taxes, levies or expenses relate d to the purchase or sale of an amount of any currency, or the patriation or repatr iation of any security or other asset, or related t o the execution of portfolio transactions or any creation or redemption transact ions); fees and expenses incurred in connection wit h securities lending; paying for sublicensing fees related to each Fund's Index and any distribution fees or expenses but excluding interest, taxes, brokerage commissions and other expenses connected with execu tion of portfolio transactions, and extraordinary e xpenses. Where the above expenses exceed the Management Fees, the Investment Manager will discharge any such expenses out of its own assets.

The fees and expenses relating to the establishment and approval of the Sub-Fund, including the fees o f the ICAV’s professional advisers, the fees and expenses incurred with respe ct to registering the shares of the Fund for sale i n various markets, and the expenses associated with the issue of shares, inclu ding the costs incurred in connection with the prep aration and publication of the Supplement, and all legal and printing costs will be borne by the Investment Manager.

8. Transaction Costs

Transaction costs are incremental costs that are di rectly attributable to the acquisition, issue or di sposal of a financial asset or financial liability. An incremental cost is one tha t would not have been incurred if the entity had no t acquired, issued or disposed of the financial instrument. When a financial asset or financial liability is recognised initially, an entity shall measure it at its fair value through profit or loss plus, transaction cost s that are directly attributable to the acquisition or issue of the financial asset or financial liability.

Transaction costs on purchases and sales of equitie s are borne by the Sub-Fund and included within net gains/(losses) on investments in the Statement of Comprehensive Incom e. Purchases and sales transaction costs include id entifiable brokerage charges, commissions, transaction related taxes and other market charges.

Transactions costs incurred on purchases and sales during the financial period ended 30 June 2021 amounted to AED 3,157.

9. Related Parties transactions

According to IAS 24 Related Parties, parties are co nsidered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions or is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. The following rel ated party relationships and transactions have been identified. The Directors, M anager and the Investment Manager are considered as key management personnel for this purpose.

The Manager is entitled to receive out of the Sub-F und’s assets an annual Management Fee of 1% of the Sub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of manage ment services and such other services as have been agreed with the Manager, incl uding the provision of company secretarial services , MLRO services and the maintenance of the ICAV’s beneficial ownership regi ster). The Manager is also entitled to be reimburse d for any reasonable and properly vouched expenses (the “Manager’s Expenses” ) as well as extraordinary expenses outside the ord inary course of business where agreed in advance with the ICAV.

Total fees earned by the Manager during the financi al period ended 30 June 2021 amounted to EUR 10,493 of which EUR 2,500 was outstanding at 30 June 2021.

The emoluments of all the Directors who are entitled to remuneration for their services as Directors in respect of any twelve-month accounting period shall not exceed €80,000 or such higher amount as may be approved by the Board of Di rectors. The Directors are also entitled to be reimbursed for their reason able out of pocket expenses incurred in discharging their duties as Directors.

Such fees and expenses are paid out of the annual management fee paid to the Manager.

Page 21

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)19

9. Related Parties transactions (continued)

Directors’ fees incurred during the financial perio d ended 30 June 2021 amounted to EUR 18,750 of whic h EUR Nil was outstanding at 30 June 2021.

The Investment Manager earned fees for investment m anagement services of AED 139,252 during the financ ial period ended 30

June 2021 of which AED 139,252 was outstanding at 3 0 June 2021. As with the other expenses, the fees a re paid out of the annual management fee paid to the Manager.

At 30 June 2021, the ICAV had two Authorised Partic ipants, International Securities L.L.C and EF Herme s UAE LLC, through which share transactions are conducted on the prima ry market. Both Authorised Participants are not rel ated to the ICAV, Directors, Manager or the Investment Manager.

At 30 June 2021, the 2 Subscriber shares were held on behalf on the ICAV by the Investment Manager.

10. Contingent Liabilities and Commitments

There were no contingent liabilities or commitments as at the financial period ended 30 June 2021.

11. Segregation of Liability

The ICAV is an umbrella fund with segregated liabil ity between Sub-Funds and each Sub-Fund may compris e one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, estab lish further Sub-Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve. The Di rectors may, from time to time, in accordance with the requirements of the CB I, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.

12. Umbrella Cash Collection Accounts

The CBI published the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) Investor Mon ey Regulations 2015 for Fund Service Providers (the “Investor Money Reg ulations” or “IMR”) in March 2015 (effective from 1 July 2016). The Management Company, together with the Administrator implemented procedures in relation to the way subs cription and redemption monies are channeled to and from the ICA V. These transactions are channeled through an umbr ella cash collection account in the name of the ICAV. Pending issue of t he shares and/or payment of subscription proceeds t o an account in the name of the ICAV or the relevant Sub-Funds, and pending payment of redemption proceeds or distributions, the relevant investor will be an unsecured creditor of the relevant Sub-Fund in r espect of amounts paid by or due to it. As at 30 Ju ne 2021 , there was no IMR related balance included within cash and cash equivalents in the Statement of Financial Position .

13. Net Asset Value Attributable to Holders of Redeemable Participating Shares

Chimera S&P UAEUCITS ETF*

As at30 June 2021

Total Net Asset Value

Class A Accumulating Shares AED 2,105,195 Class D Distributing Shares AED 59,675,098

Net Asset Value per Share

Class A Accumulating Shares AED 4.210 Class D Distributing Shares AED 4.116

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

Page 22

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)20

14. Soft Commissions

There were no soft commission arrangements entered into by the ICAV and the Sub-Fund during the financ ial period ended 30

June 2021.

15. Distributions

Distributions from Chimera S&P UAE UCITS ETF per sh are class during the financial period ended 30 June 2021 were as follows:

Share Class Ex Date Pay Date Dividend per Amount

Redeemable ParticipatingShare AEDClass D Distributing Shares 23 June 2021 30 June 2021 0.0960 1,392,000

16. Exchange Rates

The following average exchange rate was used to convert certain expense payments to AED:

Financial period ended

30 June 2021EUR 0.226581

17. Efficient Portfolio Management

The Investment Manager may, on behalf of the Sub-Fu nd and subject to the conditions and within the lim its laid down by the Central Bank of Ireland, employ techniques and inst ruments relating to transferable securities and mon ey market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Sub-Fund.

Transactions for the purposes of efficient portfoli o management may be undertaken with a view to achie ving the reduction of risk, the reduction of cost, or the generation of additio nal capital or income for the Sub-Fund with an appr opriate level of risk and taking into account the risk profile of that Fund. Techniques and instruments used for efficient portf olio management purposes may include Investments in financial derivative ins truments (“FDI”) including futures, options and swa ps, the entry into securities lending transactions, repurchase and/or reverse rep urchase agreements. All revenues arising from effic ient portfolio management activities, net of direct and indirect operational costs will be retained by the Sub-Fund and recognis ed in the Statement of Comprehensive Income.

The Sub-Fund did not engage in any efficient portfolio management activities during the financial period ended 30 June 2021.

18. Transactions with Connected Persons

Regulation 43 (1) of the Central Bank UCITS Regulat ions “Restrictions of transactions with connected p ersons” states that “A responsible person shall ensure that any transactio n between a UCITS and a connected person is conduct ed a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.

As required under the Central Bank UCITS Regulation 81 (4), the Board of Directors, as responsible per sons, are satisfied that there are arrangements in place, evidenced by writt en procedures, to ensure that obligations set out i n Regulation 43(1) are applied to all transactions with connected persons; and all transactions with connected persons that were ente red into during the financial period to which the report relates, complied with the obligations that are prescribed by Regulation 43(1).

19. Significant Events during the Financial Period

The Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

Effective 3 March 2021, a new Prospectus and Sub-Fund Supplement was issued.

Effective 28 June 2021, Mr. Hamad Al Shamsi resigne d as a Director of the ICAV while Mr. Jason Loveles s was appointed as a Director of the ICAV effective from that date also .

Other than the above, there have been no significant events that require disclosure in the financial statements.

Page 23

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

Notes to the Unaudited Financial Statements (continued)21

20. Subsequent Events after the Financial Period End

There have been no significant subsequent events after the financial period end that require disclosure in the financial statements .

21. Approval of Condensed Interim Report and Unaudited Financial Statements

The Condensed Interim Report and Unaudited financial statements were approved by the Directors on 23 August 2021 .

Page 24

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

22

Schedule of InvestmentsChimera S&P UAE UCITS ETF*As at 30 June 2021Security Description Nominal Fair Value

AED% ofNet Assets

Transferable securities admitted to an official stock exchange Equities 100.06%

United Arab Emirates 100.06%

Abu Dhabi Commercial Bank PJSC765,5335,259,2128.51

Abu Dhabi Islamic Bank PJSC248,4181,361,3312.20

Abu Dhabi National Oil Co for Distribution PJSC 686 ,1032,970,8264.81

Air Arabia PJSC622,655828,1311.34

Aldar Properties PJSC1,058,1394,042,0916.54

Amanat Holdings PJSC339,346325,7720.53

DAMAC Properties Dubai Co PJSC461,471590,6830.96

Dana Gas PJSC946,995790,7411.28

Deyaar Development PJSC400,162119,6480.19

Dubai Financial Market PJSC421,070488,4410.79

Dubai Investments PJSC577,162981,1751.59

Dubai Islamic Bank PJSC496,0252,390,8413.87

Emaar Development PJSC232,697860,9791.39

Emaar Malls PJSC540,7771,103,1851.79

Emaar Properties PJSC962,9014,005,6686.49

Emirates NBD Bank PJSC347,3654,602,5867.45

Emirates Telecommunications Group Co PJSC478,26010,521,72017.03

Eshraq Investments PJSC315,598113,6150.18

First Abu Dhabi Bank PJSC1,198,56920,016,10232.40

RAK Properties PJSC273,426173,6260.28

SHUAA Capital PSC196,686119,1920.19

Union Properties PJSC582,260154,2990.25

Total United Arab Emirates61,819,864100.06

Total Equities61,819,864100.06

Total Transferable securities admitted to an official stock exchange61,819,864100.06

Total Financial assets at fair value through profit or loss61,819,864100.06

Cash and cash equivalents99,6810.16

Other liabilities(139,252)(0.22)

Total Net assets attributable to holders of redeemable participating

shares61,780,293100.00

Analysis of total assets% ofTotalAssets

Transferable securities admitted to an official stock exchange listing 99.84 Cash and cash equivalents 0.16

Total Assets 100.00

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

Page 25

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

23Statement of Portfolio Changes

Chimera S&P UAE UCITS ETF*

Major Purchases**Security Description Nominal CostAED

First Abu Dhabi Bank PJSC1,226,62718,278,232

Emirates Telecommunications Group Co PJSC489,45210,332,896

Abu Dhabi Commercial Bank PJSC781,0094,979,049

Emirates NBD Bank PJSC354,5084,245,657

Aldar Properties PJSC1,081,5893,922,748

Emaar Properties PJSC987,2323,683,365

Abu Dhabi National Oil Co for Distribution PJSC703,5023,030,030

Dubai Islamic Bank PJSC505,0442,349,778

Abu Dhabi Islamic Bank PJSC255,2371,286,137

Emaar Malls PJSC540,777971,206

Dubai Investments PJSC577,162904,293

Air Arabia PJSC677,606878,503

Dana Gas PJSC946,995733,708

Emaar Development PJSC232,697652,125

DAMAC Properties Dubai Co PJSC486,334594,991

Dubai Financial Market PJSC421,070446,008

Amanat Holdings PJSC339,346290,977

Union Properties PJSC582,260155,509

RAK Properties PJSC273,426145,713

SHUAA Capital PSC196,686127,483

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

** In accordance with the Central Bank UCITS Regula tions, the condensed interim report and unaudited f inancial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total valu e of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 26

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

24Statement of Portfolio Changes (continued)

Chimera S&P UAE UCITS ETF*

All Sales**Security Description Nominal ProceedsAED

First Abu Dhabi Bank PJSC28,058465,946

Emirates Telecommunications Group Co PJSC11,192246,691

Abu Dhabi Commercial Bank PJSC15,476107,308

Emirates NBD Bank PJSC7,14399,454

Emaar Properties PJSC24,33199,323

Aldar Properties PJSC23,45089,029

Abu Dhabi National Oil Co for Distribution PJSC17,39975,789

Air Arabia PJSC54,95175,684

Dubai Islamic Bank PJSC9,01944,103

Abu Dhabi Islamic Bank PJSC6,81938,045

DAMAC Properties Dubai Co PJSC24,86331,756

DXB Entertainments PJSC253,74820,300

* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.

** In accordance with the Central Bank UCITS Regula tions, the condensed interim report and unaudited f inancial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total valu e of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.

Page 27

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial Statements

For the financial period from 21 January 2019 (date of registration) to 30 June 2021

25Appendix I: Securities Financing Transactions Regulation (“SFTR”)Disclosures

The ICAV is required to report in the financial sta tements on a semi-annual basis certain disclosures as set out in Article 13 of the European Commission Regulation 2015/2365 on transpa rency of securities financing transactions and of r euse of collateral (the “Regulation”).

Neither the ICAV nor the Sub-Fund engaged in any se curities financing transactions during the financia l period ended 30 June 2021, as a result, there is nothing to report in that regard.